Case report: Successful management of a refractory double-expressor diffuse large B-cell lymphoma patient under the guidance of in vitro high-throughput drug sensitivity test

Xing, LJ; Wang, H; Liu, D; He, Q; Li, ZJ

Li, ZJ (通讯作者),Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Dept Hematol, Jinan, Peoples R China.

FRONTIERS IN ONCOLOGY, 2023; 12 ():

Abstract

IntroductionDouble-expressor diffuse large B-cell lymphoma (DEL), harboring double expression of MYC and BCL2, has an inferior prognosis following sta......

Full Text Link